It was a very busy week for the Contemporary OB/GYN® team.
This week’s top articles included:
A prospective observational study found that hormone therapy resulted in a significant reduction in nocturia prevalence and bother in postmenopausal women with two nocturnal voids.
A prospective study to assess the effects of an oral contraceptive containing estetrol and drospirenone on ovarian function found treatment achieved complete ovulation inhibition.
Two experts discuss the goals of treatment and the expanding therapeutic landscape. This article was sponsored by Myovant Sciences.
Lower levels of testing and higher positivity rates, higher rates of dangerous drug combination use, and increases in fatal and non-fatal overdoses during the coronavirus disease 2019 (COVID-19) pandemic reveal a need for more resources to address the opioid epidemic in the United States.
Treating COVID-19 in pregnant patients brings extra challenges, risks.